Antoine Seyve

Groupement Hospitalier Est
Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Diagnostic Value of Spinal Cord Lesion Metabolism on [18F]FDG PET/CT for the Classification of Myelopathy.

Diagnostic Value of Spinal Cord Lesion Metabolism on [18F]FDG PET/CT for the Classification of Myelopathy.

Journal: European journal of neurology

Published: February 17, 2026

Open questions on vorasidenib.

Open questions on vorasidenib.

Journal: Current opinion in oncology

Published: October 01, 2025

CMRO2 (DSC-PW) perfusion parameter helps to distinguish between progression and pseudoprogression in patients with glioblastoma.

CMRO2 (DSC-PW) perfusion parameter helps to distinguish between progression and pseudoprogression in patients with glioblastoma.

Journal: La Radiologia medica

Published: April 23, 2025

Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort.

Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort.

Journal: Neuro-oncology

Published: October 21, 2024

Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases.

Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases.

Journal: Cancers

Published: September 13, 2024

Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.

Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.

Journal: Journal of neuro-oncology

Published: May 02, 2024

Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma.

Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma.

Journal: Frontiers in neurology

Published: November 15, 2023

Prognosis of glioblastoma patients improves significantly over time interrogating historical controls.

Prognosis of glioblastoma patients improves significantly over time interrogating historical controls.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 07, 2023

T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.

T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.

Journal: European journal of neurology

Published: February 27, 2023

Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.

Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.

Journal: Neuro-oncology

Published: August 11, 2022

RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells.

RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells.

Journal: Nature communications

Published: July 21, 2021

Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma.

Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma.

Journal: Clinical neurology and neurosurgery

Published: May 06, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026